Skip to main content

New Drugs, Immuno-Oncology Advances Gastric Cancer Treatment Paradigm

Immuno-oncology and the classification of subtypes of gastric cancer could greatly advance treatment efficacy and variation, according to Manish A. Shah, MD. – See more at: http://www.targetedonc.com/news/new-drugs-immunooncology-advances-gastric-cancer-treatment-paradigm#sthash.Nr1A9rBl.dpuf
http://www.targetedonc.com/news/new-drugs-immunooncology-advances-gastric-cancer-treatment-paradigm

AUDIENCES

SUBJECTS

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino